Ladiratuzumab

MedChem Express

Ladiratuzumab

10

Research Use Only

Monoclonal

99.76

Ladiratuzumab (hLIV22) is an anti- LIV-1/ZIP6 humanized monoclonal antibody. Ladiratuzumab, conjugated with the microtubule disrupting agent, MMAE (HY-15162) to compose SGN-LIV1A, an antibody-drug conjugate (ADC) . Ladiratuzumab can be used for research of breast cancer [1] [2] .

-80°C

12352203